Skip to main content
. 2014 May 28;12(6):3203–3217. doi: 10.3390/md12063203

Figure 2.

Figure 2

Clavatustide B inhibits growth of different cancer cells in a dose-dependent manner after 24 h (A); 48 h (B) and 72 h (C) treatments. * p < 0.05.